Effect of repeated treatment with olanzapine or olanzapine plus fluoxetine on tyrosine hydroxylase in the rat locus coeruleus

International Journal of Neuropsychopharmacology

Volumn 7, Issue 3, 2004, Pages 321-327

  Ordway, Gregory A ^a   Szebeni, Katalin ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Atypical antipsychotic; Depression; Fluoxetine; Locus coeruleus; Norepinephrine; Olanzapine; Tyrosine hydroxylase

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BRAIN ENZYME; FLUOXETINE; IMIPRAMINE; OLANZAPINE; RESERPINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; ATTENTION; BEHAVIOR; CHRONIC DRUG ADMINISTRATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; IMMUNOREACTIVITY; LOCUS CERULEUS; MODEL; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; WESTERN BLOTTING;

ACTINS; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOTTING, WESTERN; DRUG INTERACTIONS; FLUOXETINE; INJECTIONS, INTRAPERITONEAL; LOCUS COERULEUS; RATS; SEROTONIN UPTAKE INHIBITORS; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 4444373328     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004468     Document Type: Article

References (31)

1. Arnsten AF, Steere JC, Hunt RD (1996), The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Archives of General Psychiatry 53, 448-455.
2. Brady LS (1994). Stress, antiderpessant drugs, and the locus coeruleus. Brain Research Bulletin 35, 545-556.
3. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HJ (1992). The antidepressants fluoxetine, idazoxan, and phenelzine alter corticotropin- releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Research 572, 117-125.
4. Cubells JF, Kim KS, Baker H, Volpe BT, Chung Y, Houpt TA, Wessel TC, Joh TH (1995). Differential in vivo regulation of mRNA encoding the norepinephrine transporter and tyrosine hydroxylase in rat adrenal medulla and locus ceruleus. Journal of Neurochemistry 65, 502-509.
5. Cusack B, Nelson A, Richelson E (1994). Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 114, 559-565.
6. Dawe GS, Huff KD, Vandergriff JL, Sharp T, O'Neill MJ, Rasmussen K (2001). Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biological Psychiatry 50, 510-520.
7. Franowicz JS, Kessler LE, Borja CM, Kobilka BK, Limbird LE, Arnsten AF (2002). Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. Journal of Neuroscience 22, 8771-8777.
8. Frye C, Seliga A (2002). Olanzapine and progesterone have dose-dependent and additive effects to enhance lordosis and progestin concentrations in rats. Physiology and Behavior 76, 151-158.
9. Grant MM, Weiss JM (2001). Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biological Psychiatry 49, 117-129.
10. Li XM, Perry KW, Wong DT, Bymaster FP (1998). Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology (Berlin) 136, 153-161.
11. Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL (2003). Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28, 1-13.
12. Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M (2002). An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses. Journal of Clinical Psychiatry 63, 1164-1170.
13. Melia KR, Nestler EJ, Duman RS (1992a). Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats. Psychopharmacology 108, 23-26.
14. Melia KR, Rasmussen K, Terwilliger RZ, Haycock JW, Nestler EJ, Duman RS (1992b). Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. Journal of Neurochemistry 58, 494-502.
15. Nasif FJ, Cuadra GR, Ramirez OA (2000). Effects of chronic risperidone on central noradrenergic transmission. European Journal of Pharmacology 394, 67-73.
16. Nestler EJ, McMahon A, Sabban EL, Tallman JF, Duman RS (1990). Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proceedings of the National Academy of Sciences USA 87, 7522-7526.
17. Ordway GA, Klimek V (2001). Noradrenergic pathology in psychiatric disorders: postmortem studies. CNS Spectrums 6, 697-703.
18. Ordway GA, Klimek V, Mann JJ (2002). Neurocircuitry of mood disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C (Eds.), Psychopharmacology. The Fifth Generation of Progress (pp. 1051-1064). Philadelphia: Lippincott-Williams & Wilkin.
19. Ordway GA, Smith KS, Haycock JW (1994). Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. Journal of Neurochemistry 62, 680-685.
20. Paykel ES, Myers JK, Dienelt MN, Klerman GL, Lindenthal JJ, Pepper MP (1969). Life events and depression. A controlled study. Archives of General Psychiatry 21, 753-760.
21. Perez MF, Nasif FJ, Marchesini GR, Maglio LE, Ramirez OA (2001). Hippocampus and locus coeruleus activity on rats chronically treated with diazepam. Pharmacology, Biochemistry, and Behavior 69, 431-438.
22. Peterson G (1977). A simplification of the protein assay method of Lowry et al., which is more generally applicable. Analytical Biochemistry 83, 346-356.
23. Petrie JL, Sved AF, Zigmond MJ, Austin MC (2002). Cold stress increases tyrosine hydroxylase mRNA and protein levels in locus coeruleus of rats. Biological Psychiatry 51 [Abstract], 65S.
24. Ramirez OA, Wang RY (1986). Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine. Brain Research 362, 165-170.
25. Schultzberg M, Austin MC, Crawley JN, Paul SM (1991). Repeated administration of desmethylimipramine blocks reserpine-induced increase in tyrosine hydroxylase mRNA in locus coeruleus neurons of the rat. Molecular Brain Research 10, 307-314.
26. Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, Feldman PD, Meltzer HY (2001). A novel augmentation strategy for treating resistant major depression. American Journal of Psychiatry 158, 131-134.
27. Szabo ST, de Montigny C, Blier P (2000). Progressive atenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. International Journal of Neuropsychopharmacology 3, 1-11.
28. Wakade AR (1980). A comparison of rates of depletion and recovery of noradrenaline stores of peripheral and central noradrenergic neurones after reserpine administration: importance of neuronal activity. British Journal of Pharmacology 68, 93-98.
29. Weiss JM, Goodman PA, Losito BG, Corrigan S, Charry JM, Bailey WH (1981). Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Research Reviews 3, 167-205.
30. Westerink BH, De Boer P, De Vries JB, Kruse CG, Long SK (1998). Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. European Journal of Pharmacology 361, 27-33.
31. Zhu M-Y, Klimek V, Dilley GE, Haycock JW, Stockmeier CA, Overholser JC, Meltzer HY, Ordway GA (1999). Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biological Psychiatry 46, 1275-1286.